DEF 14A

Company

Protalix BioTherapeutics, Inc.

Filed

October 15, 2019

Period of Report

December 9, 2019

Accession Number

0001104659-19-054172

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →